Literature DB >> 7213525

A new technique for recording compliance of human hand veins.

W H Aellig.   

Abstract

1 A new technique for determining venous compliance at a standardized congestion pressure has been developed based on the optical method described by Nachev, Collier & Robinson (1971). It uses a linear variable differential transformer for a direct and continuous recording of venous compliance. 2 This method has been used to establish dose-response curves for the constrictor effects of noradrenaline, adrenaline, 5-hydroxytryptamine and dihydroergotamine after direct local infusion. 3 A parallel shift to the right of the noradrenaline dose-response curves was observed after local infusion of phentolamine, showing that the method can be used also to study interactions between agonists and antagonists on human veins in vivo. The usefulness of this technique for investigating the effects of orally administered drugs has also been established. The venoconstrictor action of dihydroergotamine reached its maximum after 1.5 h and remained almost constant for the period of observation (8 h).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7213525      PMCID: PMC1401623          DOI: 10.1111/j.1365-2125.1981.tb00527.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  A longitudinal study of the mechanisms of action of debrisoquine and propranolol.

Authors:  J Aminu; D W Vere
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

2.  Effect of catecholamines and other vasoactive substances on superficial hand veins in man.

Authors:  J G Collier; C Nachev; B F Robinson
Journal:  Clin Sci       Date:  1972-09       Impact factor: 6.124

3.  Simplified method for measuring compliance of superficial veins.

Authors:  C Nachev; J Collier; B Robinson
Journal:  Cardiovasc Res       Date:  1971-01       Impact factor: 10.787

4.  Venoconstrictor effect of dihydroergotamine in superficial hand veins.

Authors:  W H Aellig
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

5.  Studies on the peripheral mode of action of dihydroergotamine in human and canine veins.

Authors:  E Müller-Schweinitzer
Journal:  Eur J Pharmacol       Date:  1974-07       Impact factor: 4.432

6.  The responses of the human temporal and rabbit ear artery to 5-hydroxytryptamine and some of its antagonists.

Authors:  P R Carroll; P W Ebeling; W E Glover
Journal:  Aust J Exp Biol Med Sci       Date:  1974-10

7.  Assessment of the effect of drugs on the venous system in man.

Authors:  B F Robinson
Journal:  Br J Clin Pharmacol       Date:  1978-11       Impact factor: 4.335

8.  The effects of oral propranolol on the distensibility of resting superficial veins in man.

Authors:  J M Aminu; D W Vere
Journal:  Clin Sci       Date:  1972-01       Impact factor: 6.124

9.  [The test of venoconstriction for the measurement of sensitivity to 5-hydroxytryptamine and catecholamines in man].

Authors:  F Sicuteri; P L Del Bianco; M Fanciullacci; G Franchi
Journal:  Boll Soc Ital Biol Sper       Date:  1964-10-15

10.  Beta-adrenoceptors in the human dorsal hand vein, and the effects of propranolol and practolol on venous sensitivity to noradrenaline.

Authors:  C B White; B P Udwadia
Journal:  Br J Clin Pharmacol       Date:  1975-04       Impact factor: 4.335

View more
  56 in total

1.  Impaired beta-adrenoceptor mediated venodilation in patients with diabetes mellitus.

Authors:  K Harada; M Ohmori; Y Kitoh; K Sugimoto; A Fujimura
Journal:  Br J Clin Pharmacol       Date:  1999-04       Impact factor: 4.335

Review 2.  Assessment of venous capacitance. Radionuclide plethysmography: methodology and research applications.

Authors:  Matthias Schmitt; Daniel J Blackman; Gordon W Middleton; John R Cockcroft; Michael P Frenneaux
Journal:  Br J Clin Pharmacol       Date:  2002-12       Impact factor: 4.335

3.  Endothelial venodilator response in carriers of genetic polymorphisms involved in NO synthesis and degradation.

Authors:  Ruth Fricker; Christiane Hesse; Johanna Weiss; Yorki Tayrouz; Michael M Hoffmann; Kristina Unnebrink; Ulrich Mansmann; Walter E Haefeli
Journal:  Br J Clin Pharmacol       Date:  2004-08       Impact factor: 4.335

4.  Proceedings of the British Pharmacological Society. 12-14 September 1990, Belfast.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

5.  Effects of different congestion pressures on the diameter of the dorsal hand vein and on its apparent sensitivity to noradrenaline.

Authors:  A H Abdelmawla; R W Langley; E Szabadi; C M Bradshaw
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

6.  Comparison of the antagonistic activity of tamsulosin and doxazosin at vascular alpha 1-adrenoceptors in humans.

Authors:  K Harada; M Ohmori; A Fujimura
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

7.  Long-term effects of nasal continuous positive airway pressure on vasodilatory endothelial function in obstructive sleep apnea syndrome.

Authors:  Hans-W Duchna; Maritta Orth; Gerhard Schultze-Werninghaus; Christian Guilleminault; Riccardo A Stoohs
Journal:  Sleep Breath       Date:  2005-09       Impact factor: 2.816

8.  Attenuation by ACE inhibitor drugs of alpha-adrenoceptor sensitivity in human vessels: possible differences related to drug lipophilicity.

Authors:  M Kimura; K Umemura; K Kosuge; M Nishimoto; K Ohashi; M Nakashima
Journal:  Br J Clin Pharmacol       Date:  1998-12       Impact factor: 4.335

9.  Pharmacological tolerance to alpha 1-adrenergic receptor antagonism mediated by terazosin in humans.

Authors:  J Vincent; W Dachman; T F Blaschke; B B Hoffman
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

10.  Insulin therapy does not interfere with venous endothelial function evaluation in patients with type 2 diabetes mellitus.

Authors:  Antônio Marcos Vargas da Silva; Luciana de Moraes Penno; Marcello Casaccia Bertoluci; Maria Cláudia Irigoyen; Beatriz D'Agord Schaan
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.